Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:09 PM
Ignite Modification Date:
2025-12-24 @ 1:09 PM
NCT ID:
NCT04835961
Eligibility Criteria:
Inclusion Criteria:
* Adult patients Newly diagnosed patients with asthma without prior treatment or receiving previous low dose (LD) ICS / LABA treatment, as needed.
* Patients who are not adequately controlled with LD ICS as maintenance therapy and need to have LABA added:
* or as a maintenance treatment
* either as maintenance therapy and as an invocation to treat the symptoms.
* Patients who are not adequately controlled with LD or moderate (MD) ICS and LABA doses and need to have ICS / LABA added as an adjunctive therapy to treat the symptoms.
* Consent and compliance with the therapies and study procedures.
Exclusion Criteria:
Patients \<18
* Patients with COPD
* Patients with ACO
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04835961
Study Brief:
Protocol Section:
NCT04835961